PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Using AI, USC researchers pioneer a potential new immunotherapy approach for treating glioblastoma

A team of researchers from USC Norris Comprehensive Cancer Center built a machine learning system to identify genes that can convert brain cancer cells into functioning immune cells and successfully tested the approach in a mouse model.

2024-08-01
(Press-News.org)

In an innovative new study of glioblastoma, scientists used artificial intelligence (AI) to reprogram cancer cells, converting them into dendritic cells (DCs), which can identify cancer cells and direct other immune cells to kill them.

Glioblastoma is the most common brain cancer in adults and also the deadliest, with less than 10% of patients surviving five years after their diagnosis. While new approaches such as immunotherapy have revolutionized treatment for other cancers, they have done little for patients with glioblastoma. That is partly because these hard-to-reach brain tumors hide behind the blood-brain barrier, where immune cells struggle to reach and eliminate them.

But new research, supported in part by the National Institutes of Health and led by the Keck School of Medicine of USC, has leveraged AI to explore which genes control a cell’s fate—whether it develops into a heart cell, a lung cell or a cancer cell, for instance. The researchers identified genes that can reprogram glioblastoma cells, converting them into immune cells within the tumor itself so they effectively target their kin cancer cells for destruction.

In mouse models of glioblastoma, the approach increased the chances of survival by up to 75%. The results were just published in Cancer Immunology Research, a journal of the American Association for Cancer Research.

“This groundbreaking study leverages the power of AI to transform glioblastoma cells into immune-activating cells, marking a significant advancement in cancer immunotherapy,” said the study’s lead author David Tran, MD, PhD, an associate professor of neurological surgery and neurology and division chief of neuro-oncology at the Keck School of Medicine. “By turning the cancer's own cells against it, we are paving the way for more effective treatments and offering new hope to patients battling this and many other aggressive cancers.”

In addition to their work in animal models, researchers used AI to identify a set of genes that can convert human glioblastoma cells into immune cells. In the future, scientists could deliver that genetic material to glioblastoma patients by embedding it within an innocuous virus, a tool known as a viral vector. 

“Forcing a cell with 20,000 genes to become something else is incredibly complex. Using traditional molecular approaches, it would be almost impossible to do,” said Tran, who also co-directs the USC Brain Tumor Center at USC Norris Comprehensive Cancer Center. “AI is helping us answer some critical questions and gives us a powerful way to learn how to manipulate a cell’s fate.”

Controlling the fate of a cell

DCs play a central role in activating the immune response: They sample antigens (such as from a cancer cell) and present them to other immune cells, including armies of T-cells, effectively triggering a full-scale attack.

Evidence suggests that DCs can fight glioblastoma, but scientists have not yet found a reliable way to get them past the blood-brain barrier and into the hostile environment of a tumor. By reprogramming cancer cells already located within the tumor, Tran and his team have bypassed this major challenge.

When manipulating the fate of a cell, one important consideration is specificity. Converting healthy brain cells into DCs, for example, could shrink a brain tumor but cause health problems.

“We don’t want to give something to a patient that can convert all sorts of cells into DCs,” Tran said.

The machine learning system he and his team developed was able to query tens of thousands of genes and millions of gene-to-gene connections and identify those that can specifically target glioblastoma cells and reprogram them to resemble DCs. This AI-driven method differs from previous research, which used what is known as an empirical approach to manually identify genes that control a cell’s fate.

‘The high computational power of AI is really helping us accelerate the discovery process,” Tran said.

Used alongside other immunotherapies, reprogramming glioblastoma cells significantly enhanced the immune response and survival rates in mouse models of glioblastoma. When combined with immune checkpoint therapy, the new approach improved the chance of survival by 75%. When combined with a classic DC vaccine, the new approach doubled the chance of survival. (Used alone, neither immune checkpoint therapy nor a DC vaccine increased the chance of survival in patients with glioblastoma.)

Moving toward clinical trials

In addition to the proof-of-concept study in mice, the researchers used their AI system to identify a set of human genes that can convert human glioblastoma cells into cells resembling DCs. Next, they plan to fine-tune that list, package the genetic material into a viral vector and begin an initial round of safety and efficacy tests in animal models.

“We want to expand the search, using AI to help us find the best possible combinations as we move toward testing in patients,” Tran said.

If the approach is deemed safe and effective—meaning it improves outcomes for glioblastoma models and does not cause unexpected side effects—Tran and his team will apply for approval to begin clinical trials in patients in several years. Down the line, they also hope to use their AI model to find genes that can reprogram other types of cancer cells to behave like DCs.

About this research

In addition to Tran, the study’s other authors are Tianyi Liu, Son B. Le and Dongjiang Chen from the Division of Neuro-Oncology, Departments of Neurological Surgery and Neurology and the USC Brain Tumor Center, Keck School of Medicine of USC, University of Southern California; and Dan Jin, Mathew Sebastian, Alberto Riva and Ruixuan Liu from the University of Florida College of Medicine, Gainesville, Florida.

This work was supported by the National Cancer Institute of the National Institutes of Health [R42CA228875, R01CA238387, P30CA014089 and F30CA232641] and the Bankhead Coley Research Program of the Florida Department of Health [6BC04].

 

Disclosure: Tran and Le are inventors of two patent applications [62/952,725 and 62/586,655] based on the data in this manuscript.

END



ELSE PRESS RELEASES FROM THIS DATE:

High blood pressure associated with environmental contamination by tellurium

High blood pressure associated with environmental contamination by tellurium
2024-08-01
The likelihood of developing high blood pressure (hypertension) increases with higher levels of tellurium, a contaminant transferred from mining and manufacturing activities to foods. Improved monitoring of tellurium levels in specific foods could help decrease high blood pressure in the general population. The results of a study examining the relationship between tellurium exposure and hypertension were published in the journal Environment International.    The study was led by Nagoya University in Japan. According to Takumi Kagawa, one of the researchers involved in the ...

Pursuing the middle path to scientific discovery

Pursuing the middle path to scientific discovery
2024-08-01
In electronic technologies, key material properties change in response to stimuli like voltage or current. Scientists aim to understand these changes in terms of the material’s structure at the nanoscale (a few atoms) and microscale (the thickness of a piece of paper). Often neglected is the realm between, the mesoscale — spanning 10 billionths to 1 millionth of a meter. Scientists at the U.S. Department of Energy’s (DOE) Argonne National Laboratory, in collaboration with Rice University and DOE’s Lawrence ...

Salk awarded $3.6 million by the California Institute for Regenerative Medicine to advance research on brain aging

Salk awarded $3.6 million by the California Institute for Regenerative Medicine to advance research on brain aging
2024-08-01
LA JOLLA (July 31, 2024)—The Salk Institute was awarded $3.6 million by the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine. Salk Professor Rusty Gage will lead the new CIRM-funded Shared Resources Laboratory focused on stem cell-based models of aging and neurodegeneration. The award is part of CIRM’s latest round of funding to address challenges in the regenerative medicine field. The state agency dedicated $27 million to help establish six new Shared Resources ...

Generation X and millennials in US have higher risk of developing 17 cancers compared to older generations, new study suggests

Generation X and millennials in US have higher risk of developing 17 cancers compared to older generations, new study suggests
2024-08-01
A new large study led by researchers at the American Cancer Society (ACS) suggests incidence rates continued to rise in successively younger generations in 17 of the 34 cancer types, including breast, pancreatic, and gastric cancers. Mortality trends also increased in conjunction with the incidence of liver (female only), uterine corpus, gallbladder, testicular, and colorectal cancers. The report will be published today in the journal The Lancet Public Health. “These findings add to growing evidence of increased cancer risk in post-Baby Boomer ...

Around 160,000 joint replacement surgeries lost by COVID-19 pandemic, study finds

2024-08-01
Nearly nine months of joint replacement surgery has been lost - around 160,000 fewer operations –  since the start of the COVID-19 pandemic, a new study led by the University of Bristol has found.  The research suggests returning to pre-pandemic levels will not tackle the backlog, and even with rapid expansion, it will take many years, if not decades, to fix this joint replacement crisis. The study, published in The Bone & Joint Journal today [1 August], looked in detail at the effect ...

Public health measures that reduce dementia risk could save up to £4bn

2024-07-31
Public health interventions that tackle dementia risk factors could yield as much as £4bn in savings in England by reducing dementia rates and helping people to live longer and healthier, finds a new study led by UCL researchers. The study, published in The Lancet Healthy Longevity, shows that interventions – such as reformulating food products to reduce sugar and salt intake, introducing low emission zones to improve air quality in cities, and minimum alcohol unit pricing to reduce drinking – could have extensive benefits beyond just the health outcomes they are directly targeting. Lead author Dr Naaheed Mukadam (UCL Psychiatry) ...

The Lancet: Nearly half of dementia cases could be prevented or delayed by tackling 14 risk factors starting in childhood, including two new risks—high cholesterol and vision loss

2024-07-31
Vision loss and high cholesterol add to 12 previously identified modifiable risk factors for dementia, concludes a new report from the 2024 Lancet Commission. The potential to prevent and better manage dementia is high if action to tackle these risk factors begins in childhood and continues throughout life, even in individuals with high genetic risk for dementia. New report outlines 13 recommendations for individuals and governments to help reduce risk, including preventing and treating hearing loss, vision loss, and depression; being cognitively active ...

Precision oncology via artificial intelligence on cancer biopsies

Precision oncology via artificial intelligence on cancer biopsies
2024-07-31
A new generation of artificial intelligence (AI) tools designed to allow rapid, low-cost detection of clinically actionable genomic alterations directly from tumor biopsy slides has been developed by a team led by engineers and medical researchers at University of California San Diego. A paper describing the new AI protocol for examining routine biopsies, called DeepHRD, was recently published in the Journal of Clinical Oncology. Senior author Ludmil Alexandrov, Ph.D., professor of bioengineering and professor of cellular and molecular medicine at UC San Diego, says the new method is designed to save weeks and thousands of dollars from clinical oncology treatment workflows ...

What you don't know about endometrial cancer could kill you

2024-07-31
CLEVELAND, Ohio (July 31, 2024)—Despite the fact that endometrial cancer is the most common cancer of the female reproductive organs, a significant percentage of women do not know that postmenopausal bleeding is a key warning sign of the disease. Worse, even fewer women report having received any type of counseling on the subject from their healthcare professionals. That’s according to a new study published online today in Menopause, the journal of The Menopause Society. It is estimated that 67,880 new cases of ...

Does it matter that the ovaries are the most rapidly aging organs in the female body?

2024-07-31
CLEVELAND, Ohio (August 1, 2024)—Because of the aging of the ovaries, a woman’s fertility gradually declines, and she eventually enters menopause. The onset of menopause puts women at a significantly higher risk of various diseases such as cardiovascular disease and osteoporosis. A new study suggests that a shorter reproductive lifespan is linked with a higher risk of multimorbidity. Results of the survey are published online today in Menopause, the journal of The Menopause Society. The effect of reproductive-related factors on women’s health has become a focus of interest and study in recent years. Previous studies have identified the ...

LAST 30 PRESS RELEASES:

Toxic metals linked to impaired growth in infants in Guatemala

Being consistently physically active in adulthood linked to 30–40% lower risk of death

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Children’s social care involvement common to nearly third of UK mums who died during perinatal period

‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths

Ethnic minority and poorer children more likely to die in intensive care

Major progress in fertility preservation after treatment for cancer of the lymphatic system

Fewer complications after additional ultrasound in pregnant women who feel less fetal movement

Environmental impact of common pesticides seriously underestimated

The Milky Way could be teeming with more satellite galaxies than previously thought

New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly

Media Tip Sheet: Symposia at ESA2025

NSF CAREER Award will power UVA engineer’s research to improve drug purification

Tiny parasitoid flies show how early-life competition shapes adult success

New coating for glass promises energy-saving windows

Green spaces boost children’s cognitive skills and strengthen family well-being

Ancient trees dying faster than expected in Eastern Oregon

Study findings help hone precision of proven CVD risk tool

Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later

Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles

Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans

New research shows how tropical plants manage rival insect tenants by giving them separate ‘flats’

Condo-style living helps keep the peace inside these ant plants

Climate change action could dramatically limit rising UK heatwave deaths

Annual heat-related deaths projected to increase significantly due to climate and population change

Researchers discover new way cells protect themselves from damage

Rivers choose their path based on erosion — a discovery that could transform flood planning and restoration

New discovery reveals dopamine operates with surgical precision, not as a broad signal

New AI tool gives a helping hand to x ray diagnosis

New Leicester study reveals hidden heart risks in women with Type 2 Diabetes

[Press-News.org] Using AI, USC researchers pioneer a potential new immunotherapy approach for treating glioblastoma
A team of researchers from USC Norris Comprehensive Cancer Center built a machine learning system to identify genes that can convert brain cancer cells into functioning immune cells and successfully tested the approach in a mouse model.